Age, comorbidity burden and late presentation are significant predictors of hospitalization length and acute respiratory failure in patients with influenza
Influenza viruses are responsible for a high number of infections and hospitalizations every year.
News
Policy & Recommendations
Flash Report: Fourth meeting of the Public Health Expert Group (PHEG)
Representatives of EU Member States agreed on the launch of a call for best and promising practices on prevention, mapping of prevention policies and updating the Healthier Together guidance document by including new focus on lifelong prevention.
News
Policy & Recommendations
European Health Union: Council calls on Commission to keep health as a priority
EU Health Ministers highlighted the ongoing challenges facing the EU’s health system, including health workforce shortages, security of supply of medicines, prevention of non-communicable diseases, as well as preparedness and communicable diseases.
Acute Cardiac Events in Hospitalized Older Adults With Respiratory Syncytial Virus Infection
Respiratory syncytial virus (RSV) infection can cause severe respiratory illness in older adults.
Mobilising Healthcare Professionals to Champion Vaccination
The Coalition for Life Course Immunisation releases a podcast episode exploring the vital role of healthcare workers in enhancing vaccine acceptance across Europe. Hosted by Gary Finnegan, editor of Vaccines Today, with guest Dr. Angelos Kassianos.
A chimeric haemagglutinin-based universal influenza virus vaccine boosts human cellular immune responses directed towards the conserved haemagglutinin stalk domain and the viral nucleoprotein
The development of a universal influenza virus vaccine, to protect against both seasonal and pandemic influenza A viruses, is a long-standing public health goal.
Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol
Nirsevimab has been recently licensed for universal RSV prophylaxis in infants. NIRSE-GAL is a three-year population-based study initiated in Galicia in September 2023.
|
9th Influenza Conference 2023
Scientific highlights of the 9th ESWI Influenza Conference
With promising developments in the field of respiratory viral infections, the conference sessions covered hot topics on seasonal, pandemic, and zoonotic influenza viruses, as well as other respiratory viruses such as RSV and SARS-CoV-2.
News
Policy & Recommendations
WHO Europe launches the first Pan-European Network for Disease Control
Hosted by UKHSA and initially chaired by Dame Jenny Harries, the new Network will strengthen disease surveillance and outbreak response across the European Region
News
Policy & Recommendations
European Parliament’s last Eurobarometer survey before the elections in June
Health is one of the main issues on the minds of voters (32%) together with the fight against poverty and social exclusion (33%).
Socio-Economic Value of Adult Immunisation Programmes report
Adult vaccines can return up to 19 times their initial investment to society, when their significant benefits beyond the healthcare system are monetised. This report has been conducted by the Office of Health Economics.
News
Policy & Recommendations
Health emergency response governance in the EU after the COVID-19 pandemic
More than four years on since the start of the Covid-19 pandemic, this paper provides an assessment of reforms implemented at EU level to enhance the EU’s preparedness and response to future health threats.